BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 26474466)

  • 1. Loss of muscle mass: Current developments in cachexia and sarcopenia focused on biomarkers and treatment.
    Drescher C; Konishi M; Ebner N; Springer J
    Int J Cardiol; 2016 Jan; 202():766-72. PubMed ID: 26474466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatment.
    Drescher C; Konishi M; Ebner N; Springer J
    J Cachexia Sarcopenia Muscle; 2015 Dec; 6(4):303-11. PubMed ID: 26676067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cachexia and sarcopenia: mechanisms and potential targets for intervention.
    Argilés JM; Busquets S; Stemmler B; López-Soriano FJ
    Curr Opin Pharmacol; 2015 Jun; 22():100-6. PubMed ID: 25974750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism of sarcopenia and cachexia: recent research advances.
    Sakuma K; Aoi W; Yamaguchi A
    Pflugers Arch; 2017 Jun; 469(5-6):573-591. PubMed ID: 28101649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia.
    Biolo G; Cederholm T; Muscaritoli M
    Clin Nutr; 2014 Oct; 33(5):737-48. PubMed ID: 24785098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcopenia, cachexia, and muscle performance in heart failure: Review update 2016.
    Saitoh M; Ishida J; Doehner W; von Haehling S; Anker MS; Coats AJS; Anker SD; Springer J
    Int J Cardiol; 2017 Jul; 238():5-11. PubMed ID: 28427849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel therapeutic options for cachexia and sarcopenia.
    Molfino A; Amabile MI; Rossi Fanelli F; Muscaritoli M
    Expert Opin Biol Ther; 2016 Oct; 16(10):1239-44. PubMed ID: 27382931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal muscle loss: cachexia, sarcopenia, and inactivity.
    Evans WJ
    Am J Clin Nutr; 2010 Apr; 91(4):1123S-1127S. PubMed ID: 20164314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle wasting: an overview of recent developments in basic research.
    Palus S; von Haehling S; Springer J
    Int J Cardiol; 2014 Oct; 176(3):640-4. PubMed ID: 25205489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The wasting continuum in heart failure: from sarcopenia to cachexia.
    von Haehling S
    Proc Nutr Soc; 2015 Nov; 74(4):367-77. PubMed ID: 26264581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms and treatment targets of muscle wasting and cachexia in heart failure: an overview.
    Ebner N; Elsner S; Springer J; von Haehling S
    Curr Opin Support Palliat Care; 2014 Mar; 8(1):15-24. PubMed ID: 24452279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological and functional failure in chronic obstructive pulmonary disease, congestive heart failure and cancer: a debilitating intersection of sarcopenia, cachexia and breathlessness.
    Dudgeon D; Baracos VE
    Curr Opin Support Palliat Care; 2016 Sep; 10(3):236-41. PubMed ID: 27380222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highlights of the mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology.
    Anker MS; von Haehling S; Springer J; Banach M; Anker SD
    Int J Cardiol; 2013 Jan; 162(2):73-6. PubMed ID: 23174169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Ontology (GO)-Driven Inference of Candidate Proteomic Markers Associated with Muscle Atrophy Conditions.
    Stalmach A; Boehm I; Fernandes M; Rutter A; Skipworth RJE; Husi H
    Molecules; 2022 Aug; 27(17):. PubMed ID: 36080280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. For an operational definition of cachexia.
    Pepersack T
    Lancet Oncol; 2011 May; 12(5):423-4. PubMed ID: 21536223
    [No Abstract]   [Full Text] [Related]  

  • 16. Sex Differences in Muscle Wasting.
    Anderson LJ; Liu H; Garcia JM
    Adv Exp Med Biol; 2017; 1043():153-197. PubMed ID: 29224095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive proteome analysis of human skeletal muscle in cachexia and sarcopenia: a pilot study.
    Ebhardt HA; Degen S; Tadini V; Schilb A; Johns N; Greig CA; Fearon KCH; Aebersold R; Jacobi C
    J Cachexia Sarcopenia Muscle; 2017 Aug; 8(4):567-582. PubMed ID: 28296247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal muscle wasting after a severe burn is a consequence of cachexia and sarcopenia.
    Song J; Clark A; Wade CE; Wolf SE
    JPEN J Parenter Enteral Nutr; 2021 Nov; 45(8):1627-1633. PubMed ID: 34296448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. THE RENIN-ANGIOTENSIN SYSTEM AND THE BIOLOGY OF SKELETAL MUSCLE: MECHANISMS OF MUSCLE WASTING IN CHRONIC DISEASE STATES.
    Delafontaine P; Yoshida T
    Trans Am Clin Climatol Assoc; 2016; 127():245-258. PubMed ID: 28066057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D, muscle recovery, sarcopenia, cachexia, and muscle atrophy.
    Garcia M; Seelaender M; Sotiropoulos A; Coletti D; Lancha AH
    Nutrition; 2019 Apr; 60():66-69. PubMed ID: 30529188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.